{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T07:19:05Z","timestamp":1772608745768,"version":"3.50.1"},"reference-count":206,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"crossref","award":["JR15\/00012"],"award-info":[{"award-number":["JR15\/00012"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"crossref","award":["PI16\/00187"],"award-info":[{"award-number":["PI16\/00187"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"crossref","award":["CM15\/00127"],"award-info":[{"award-number":["CM15\/00127"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003329","name":"Ministry of Economy and Competitiveness","doi-asserted-by":"crossref","award":["PI15\/00283"],"award-info":[{"award-number":["PI15\/00283"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003329","name":"Ministry of Economy and Competitiveness","doi-asserted-by":"crossref","award":["PI12\/00912"],"award-info":[{"award-number":["PI12\/00912"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003329","name":"Ministry of Economy and Competitiveness","doi-asserted-by":"crossref","award":["PI16\/00187"],"award-info":[{"award-number":["PI16\/00187"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100006751","name":"CIBERSAM","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006751","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Comissionat per a Universitats i Recerca del DIUE de la Generalitat de Catalunya","award":["2014 SGR 398"],"award-info":[{"award-number":["2014 SGR 398"]}]},{"DOI":"10.13039\/501100001778","name":"Deakin University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001778","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.jad.2017.06.034","type":"journal-article","created":{"date-parts":[[2017,6,20]],"date-time":"2017-06-20T17:31:29Z","timestamp":1497979889000},"page":"205-221","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":67,"special_numbering":"C","title":["Treatment of neurocognitive symptoms in unipolar depression: A systematic review and future perspectives"],"prefix":"10.1016","volume":"221","author":[{"given":"E.","family":"Salagre","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Sol\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Tomioka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.S.","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Hidalgo-Mazzei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Garriga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Jimenez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Sanchez-Moreno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Vieta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Grande","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2017.06.034_bib1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ajp.2015.04.002","article-title":"Memantine in the prevention or alleviation of electroconvulsive therapy induces cognitive disorders: a placebo controlled trial","volume":"15","author":"Abbasinazari","year":"2015","journal-title":"Asian J. Psychiatr."},{"key":"10.1016\/j.jad.2017.06.034_bib2","unstructured":"Action-Based Cognitive Remediation to Improve Vocational Outcomes in Depression \u2013 Full Text View \u2013 ClinicalTrials.gov, [WWW Document], n.d. URL \u3008https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02535390\u3009."},{"key":"10.1016\/j.jad.2017.06.034_bib3","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1212\/WNL.57.8.1515","article-title":"Controlled trial of N-acetylcysteine for patients with probable Alzheimer's disease","volume":"57","author":"Adair","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.jad.2017.06.034_bib4","unstructured":"Adjunctive Transcranial Direct Current Stimulation for Cognition in Major Depression \u2013 Full Text View \u2013 ClinicalTrials.gov [WWW Document], n.d. URL \u3008https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00760097\u3009."},{"key":"10.1016\/j.jad.2017.06.034_bib5","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1517\/14740338.2015.1046836","article-title":"Vortioxetine: a review of efficacy, safety and tolerability with a focus on cognitive symptoms in major depressive disorder","volume":"14","author":"Al-Sukhni","year":"2015","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.jad.2017.06.034_bib6","unstructured":"An Eight-week Study of SSR411298 as Treatment for Major Depressive Disorder in Elderly Patients \u2013 Full Text View \u2013 ClinicalTrials.gov [WWW Document], n.d. URL \u3008https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00822744\u3009."},{"key":"10.1016\/j.jad.2017.06.034_bib7","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1177\/0269881111424928","article-title":"Effects of omega-3 fatty acid supplementation on mood and emotional information processing in recovered depressed individuals","volume":"26","author":"Antypa","year":"2012","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jad.2017.06.034_bib8","unstructured":"Aripiprazole Augmentation of SSRI Therapy in Treatment Refractory Depression \u2013 Full Text View \u2013 ClinicalTrials.gov [WWW Document], n.d. URL \u3008https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00608543\u3009."},{"key":"10.1016\/j.jad.2017.06.034_bib9","unstructured":"Assessment in Work Productivity and the Relationship With Cognitive Symptoms in Patients With MDD Taking Vortioxetine \u2013 Full Text View \u2013 ClinicalTrials.gov [WWW Document], n.d. URL \u3008https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02332954\u3009."},{"key":"10.1016\/j.jad.2017.06.034_bib10","unstructured":"Assessment of Cognitive Functioning Before and After Treatment With Duloxetine \u2013 Full Text View \u2013 ClinicalTrials.gov [WWW Document], n.d. URL \u3008https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00933439\u3009."},{"key":"10.1016\/j.jad.2017.06.034_bib11","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0165-1781(00)00222-5","article-title":"Effect of apomorphine on motor and cognitive function in melancholic patients: a preliminary report","volume":"97","author":"Austin","year":"2000","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2017.06.034_bib12","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/0006-3223(91)90179-P","article-title":"Memory effects of clomipramine treatment: relationship to CSF monoamine metabolites and drug concentrations in plasma","volume":"30","author":"Bartfai","year":"1991","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2017.06.034_bib13","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jad.2015.08.041","article-title":"Cognitive and psychomotor effects of three months of escitalopram treatment in elderly patients with major depressive disorder","volume":"188","author":"Beheydt","year":"2015","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2017.06.034_bib14","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.schres.2011.05.015","article-title":"The effect of adjunctive armodafinil on cognitive performance and psychopathology in antipsychotic-treated patients with schizophrenia\/schizoaffective disorder: a randomized, double-blind, placebo-controlled trial","volume":"130","author":"Bobo","year":"2011","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jad.2017.06.034_bib15","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3109\/15622975.2015.1091501","article-title":"Electroconvulsive therapy and cognitive functions in treatment-resistant depression","volume":"17","author":"Bodnar","year":"2016","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2017.06.034_bib16","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jad.2006.10.026","article-title":"Go-no-go task performance improvement after anodal transcranial DC stimulation of the left dorsolateral prefrontal cortex in major depression","volume":"101","author":"Boggio","year":"2007","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2017.06.034_bib17","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12916-016-0560-3","article-title":"Cognitive remission: a novel objective for the treatment of major depression?","volume":"14","author":"Bortolato","year":"2016","journal-title":"BMC Med."},{"key":"10.1016\/j.jad.2017.06.034_bib18","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1097\/NMD.0b013e31829c5030","article-title":"Cognitive remediation for treatment-resistant depression: effects on cognition and functioning and the role of online homework","volume":"201","author":"Bowie","year":"2013","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.jad.2017.06.034_bib19","unstructured":"Brain Aging and Treatment Response in Geriatric Depression \u2013 Full Text View \u2013 ClinicalTrials.gov [WWW Document], n.d. URL \u3008https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01902004\u3009."},{"key":"10.1016\/j.jad.2017.06.034_bib20","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/WNN.0b013e31826df7fd","article-title":"Impact of armodafinil on cognition in multiple sclerosis: a randomized, double-blind crossover pilot study","volume":"25","author":"Bruce","year":"2012","journal-title":"Cogn. Behav. Neurol."},{"key":"10.1016\/j.jad.2017.06.034_bib21","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jad.2016.03.066","article-title":"Cognitive effects of transcranial direct current stimulation in depression: results from the SELECT-TDCS trial and insights for further clinical trials","volume":"202","author":"Brunoni","year":"2016","journal-title":"J. Affect. Disord."},{"issue":"1","key":"10.1016\/j.jad.2017.06.034_bib22","doi-asserted-by":"crossref","first-page":"103","DOI":"10.4088\/JCP.11m07299","article-title":"A placebo-controlled adjunctive trial of pramipexole in patients with bipolar disorder: targeting cognitive dysfunction","volume":"73","author":"Burdick","year":"2012","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2017.06.034_bib23","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.4088\/JCP.13m08951","article-title":"Efficacy and safety of adjunctive armodafinil in adults with major depressive episodes associated with bipolar I disorder: a randomized, double-blind, placebo-controlled, multicenter trial","volume":"75","author":"Calabrese","year":"2014","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2017.06.034_bib24","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.2174\/1871527313666141130203627","article-title":"Cognitive dysfunction in depression \u2013 pathophysiology and novel targets","volume":"13","author":"Carvalho","year":"2014","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.jad.2017.06.034_bib25","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jad.2016.12.006","article-title":"A randomized, double-blind, placebo-controlled, crossover trial evaluating the effect of intranasal insulin on cognition and mood in individuals with treatment-resistant major depressive disorder","volume":"210","author":"Cha","year":"2016","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2017.06.034_bib26","first-page":"455","article-title":"Cognitive dysfunction and work productivity in major depressive disorder","volume":"16","author":"Clark","year":"2016","journal-title":"Expert Rev. Pharm. Outcomes Res."},{"key":"10.1016\/j.jad.2017.06.034_bib27","unstructured":"Cognitive Dysfunction and Glucagon-like Peptide-1 Agonists \u2013 Full Text View \u2013 ClinicalTrials.gov [WWW Document], n.d. URL \u3008https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02423824\u3009."},{"key":"10.1016\/j.jad.2017.06.034_bib28","unstructured":"Combination Treatment Study for Memory Impairment and Depression (DEP-CI), [WWW Document], n.d. URL \u3008https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01658228\u3009."},{"key":"10.1016\/j.jad.2017.06.034_bib29","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/da.20060","article-title":"Effects of sertraline on depressive symptoms and attentional and executive functions in major depression","volume":"21","author":"Constant","year":"2005","journal-title":"Depression Anxiety"},{"key":"10.1016\/j.jad.2017.06.034_bib30","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1177\/0269881114552744","article-title":"Investigation of the effects of solid lipid curcumin on cognition and mood in a healthy older population","volume":"29","author":"Cox","year":"2015","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jad.2017.06.034_bib31","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1097\/JGP.0b013e3181b4bf4a","article-title":"Change in cognitive functioning following acute antidepressant treatment in late-life depression","volume":"17","author":"Culang","year":"2009","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.jad.2017.06.034_bib32","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1002\/gps.2783","article-title":"Change in cognitive functioning in depressed older adults following treatment with sertraline or nortriptyline","volume":"27","author":"Culang-Reinlieb","year":"2012","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.jad.2017.06.034_bib33","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.4088\/JCP.v64n0911","article-title":"Adjunct modafinil for the short-term treatment of fatigue and sleepiness in patients with major depressive disorder: a preliminary double-blind, placebo-controlled study","volume":"64","author":"DeBattista","year":"2003","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2017.06.034_bib34","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/01.jcp.0000104910.75206.b9","article-title":"A prospective trial of modafinil as an adjunctive treatment of major depression","volume":"24","author":"DeBattista","year":"2004","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2017.06.034_bib35","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1017\/S1461145712000326","article-title":"Use of adjunctive stimulants in adult bipolar depression","volume":"16","author":"Dell\u2019Osso","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2017.06.034_bib36","unstructured":"Depressed Mood Improvement Through Nicotine Dosing (Depressed MIND Study) \u2013 Full Text View \u2013 ClinicalTrials.gov [WWW Document], n.d. URL \u3008https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02816138\u3009."},{"key":"10.1016\/j.jad.2017.06.034_bib37","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.nut.2015.04.019","article-title":"The effect of 12-wk omega-3 fatty acid supplementation on in vivo thalamus glutathione concentration in patients \u201cat risk\u201d for major depression","volume":"31","author":"Duffy","year":"2015","journal-title":"Nutrition"},{"key":"10.1016\/j.jad.2017.06.034_bib38","unstructured":"Effectiveness of Methylphenidate in Improving Cognition and Function in Older Adults With Depression, [WWW Document], n.d. URL: \u3008https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00602290\u3009."},{"key":"10.1016\/j.jad.2017.06.034_bib39","unstructured":"Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder \u2013 Full Text View \u2013 ClinicalTrials.gov [WWW Document], n.d. URL \u3008https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01436162\u3009."},{"key":"10.1016\/j.jad.2017.06.034_bib40","unstructured":"Efficacy of Vortioxetine Versus Escitalopram on Cognitive Function in Patients With Inadequate Response to Current Antidepressant Treatment of Major Depressive Disorder \u2013 Full Text View \u2013 ClinicalTrials.gov [WWW Document], n.d. URL \u3008https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02272517\u3009."},{"key":"10.1016\/j.jad.2017.06.034_bib41","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/JCP.0b013e318172756c","article-title":"Galantamine as an adjunctive treatment in major depression","volume":"28","author":"Elgamal","year":"2008","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2017.06.034_bib42","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1017\/S0033291707001110","article-title":"Successful computer-assisted cognitive remediation therapy in patients with unipolar depression: a proof of principle study","volume":"37","author":"Elgamal","year":"2007","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jad.2017.06.034_bib43","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1007\/s00213-015-3953-7","article-title":"New onset executive function difficulties at menopause: a possible role for lisdexamfetamine","volume":"232","author":"Epperson","year":"2015","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jad.2017.06.034_bib44","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1017\/S0033291709991243","article-title":"Using the Cambridge Neuropsychological Test Automated Battery (CANTAB) to assess the cognitive impact of electroconvulsive therapy on visual and visuospatial memory","volume":"40","author":"Falconer","year":"2010","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jad.2017.06.034_bib45","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/10401230701464858","article-title":"Modafinil augmentation of selective serotonin reuptake inhibitor therapy in MDD partial responders with persistent fatigue and sleepiness","volume":"19","author":"Fava","year":"2007","journal-title":"Ann. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2017.06.034_bib46","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/j.jpsychires.2012.08.013","article-title":"An exploratory study of combination buspirone and melatonin SR in Major Depressive Disorder (MDD): a possible role for neurogenesis in drug discovery","volume":"46","author":"Fava","year":"2012","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2017.06.034_bib47","first-page":"9","article-title":"Reboxetine versus paroxetine versus placebo: effects on cognitive functioning in depressed patients","volume":"18","author":"Ferguson","year":"2003","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2017.06.034_bib48","unstructured":"Fish Oil Supplementation in Late-life Depression \u2013 Full Text View \u2013 ClinicalTrials.gov [WWW Document], n.d. URL \u3008https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01235533\u3009."},{"key":"10.1016\/j.jad.2017.06.034_bib49","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/da.20454","article-title":"A randomized trial of the anti-depressant effects of low- and high-frequency transcranial magnetic stimulation in treatment-resistant depression","volume":"26","author":"Fitzgerald","year":"2009","journal-title":"Depression Anxiety"},{"issue":"17","key":"10.1016\/j.jad.2017.06.034_bib50","first-page":"30019","article-title":"Methylphenidate, modafinil, and caffeine for cognitive enhancement in chess: a double-blind, randomised controlled trial","volume":"S0924-977X","author":"Franke","year":"2017","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2017.06.034_bib51","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/da.20201","article-title":"Cognitive effects of repeated sessions of transcranial direct current stimulation in patients with depression","volume":"23","author":"Fregni","year":"2006","journal-title":"Depression Anxiety"},{"key":"10.1016\/j.jad.2017.06.034_bib52","unstructured":"Functional Neuroimaging in Depression \u2013 Full Text View \u2013 ClinicalTrials.gov [WWW Document], n.d. URL \u3008https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00343070\u3009."},{"key":"10.1016\/j.jad.2017.06.034_bib53","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s00213-005-0274-2","article-title":"Cognitive performance in depressed patients after chronic use of antidepressants","volume":"185","author":"Gorenstein","year":"2006","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jad.2017.06.034_bib54","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.psychres.2014.12.004","article-title":"Treatment-related improvement in neuropsychological functioning in suicidal depressed patients: paroxetine vs. bupropion","volume":"225","author":"Gorlyn","year":"2015","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2017.06.034_bib55","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.4088\/JCP.13r08560","article-title":"Modafinil augmentation therapy in unipolar and bipolar depression: a systematic review and meta-analysis of randomized controlled trials","volume":"74","author":"Goss","year":"2013","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2017.06.034_bib56","first-page":"627863","article-title":"Does duloxetine improve cognitive function independently of its antidepressant effect in patients with major depressive disorder and subjective reports of cognitive dysfunction?","volume":"2014","author":"Greer","year":"2014","journal-title":"Depression Res. Treat."},{"key":"10.1016\/j.jad.2017.06.034_bib57","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.euroneuro.2014.10.001","article-title":"Dose-dependent changes in cognitive function with exercise augmentation for major depression: results from the TREAD study","volume":"25","author":"Greer","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2017.06.034_bib58","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.psychres.2014.11.079","article-title":"Effects of remission speed and improvement of cognitive functions of depressed patients","volume":"226","author":"Gudayol-Ferre","year":"2015","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2017.06.034_bib59","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/1440-1681.12265","article-title":"Metformin may produce antidepressant effects through improvement of cognitive function among depressed patients with diabetes mellitus","volume":"41","author":"Guo","year":"2014","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.jad.2017.06.034_bib60","first-page":"304","article-title":"Enduring cognitive dysfunction in unipolar major depression: a test-retest study using the Stroop paradigm","volume":"51","author":"Hammar","year":"2010","journal-title":"Scand. J. Psychol."},{"issue":"10","key":"10.1016\/j.jad.2017.06.034_bib61","doi-asserted-by":"crossref","first-page":"pyw054","DOI":"10.1093\/ijnp\/pyw054","article-title":"Which Cognitive Domains are Improved by Treatment with Vortioxetine?","volume":"19","author":"Harrison","year":"2016","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2017.06.034_bib62","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jad.2010.11.011","article-title":"Cognitive impairment in the remitted state of unipolar depressive disorder: a systematic review","volume":"134","author":"Hasselbalch","year":"2011","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2017.06.034_bib63","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1038\/mp.2015.212","article-title":"Revisiting adult neurogenesis and the role of erythropoietin for neuronal and oligodendroglial differentiation in the hippocampus","volume":"21","author":"Hassouna","year":"2016","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.jad.2017.06.034_bib64","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.psychres.2007.04.012","article-title":"Cognitive predictors of treatment response to bupropion and cognitive effects of bupropion in patients with major depressive disorder","volume":"160","author":"Herrera-Guzman","year":"2008","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2017.06.034_bib65","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.psychres.2010.03.006","article-title":"Effects of selective serotonin reuptake and dual serotonergic-noradrenergic reuptake treatments on attention and executive functions in patients with major depressive disorder","volume":"177","author":"Herrera-Guzman","year":"2010","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2017.06.034_bib66","first-page":"1","article-title":"Manual Cochrane de revisiones sistem\u00e1ticas de intervenciones","author":"Higgins","year":"2011","journal-title":"Cochrane"},{"key":"10.1016\/j.jad.2017.06.034_bib67","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1249\/MSS.0b013e31816b877c","article-title":"Exercise fails to improve neurocognition in depressed middle-aged and older adults","volume":"40","author":"Hoffman","year":"2008","journal-title":"Med. Sci. Sports Exerc."},{"key":"10.1016\/j.jad.2017.06.034_bib68","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/gps.1951","article-title":"A double blind, placebo-controlled pilot study of galantamine augmentation of antidepressant treatment in older adults with major depression","volume":"23","author":"Holtzheimer","year":"2008","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.jad.2017.06.034_bib69","unstructured":"Home-Based CR and tDCS to Enhance Cognition in Persons With Mild Cognitive Impairment and Late Life Depression \u2013 Full Text View \u2013 ClinicalTrials.gov [WWW Document], n.d. URL \u3008https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02959502\u3009."},{"key":"10.1016\/j.jad.2017.06.034_bib70","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00406-003-0416-7","article-title":"Antidepressant efficacy of two different rTMS procedures. High frequency over left versus low frequency over right prefrontal cortex compared with sham stimulation","volume":"253","author":"H\u00f6ppner","year":"2003","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.jad.2017.06.034_bib71","unstructured":"Imaging Antidepressant vs. Cognitive Behavior Therapy Effects on Unipolar Depression (ssrifMRI) \u2013 Full Text View \u2013 ClinicalTrials.gov [WWW Document], n.d. URL \u3008https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00787501\u3009."},{"key":"10.1016\/j.jad.2017.06.034_bib72","unstructured":"Impact of tDCS on Emotional Processing in Major Depression (EmoStim) \u2013 Full Text View \u2013 ClinicalTrials.gov [WWW Document], n.d. URL \u3008https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02793258\u3009."},{"key":"10.1016\/j.jad.2017.06.034_bib73","unstructured":"Investigating tDCS as a Treatment for Unipolar and Bipolar Depression \u2013 Full Text View \u2013 ClinicalTrials.gov [WWW Document], n.d. URL \u3008https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01562184\u3009."},{"key":"10.1016\/j.jad.2017.06.034_bib74","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.pnpbp.2005.08.016","article-title":"A double-blind sham controlled study of right prefrontal repetitive transcranial magnetic stimulation (rTMS): therapeutic and cognitive effect in medication free unipolar depression during 4 weeks","volume":"30","author":"Januel","year":"2006","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2017.06.034_bib75","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/JCP.0000000000000072","article-title":"Improvement in subjective and objective neurocognitive functions in patients with major depressive disorder: a 12-week, multicenter, randomized trial of tianeptine versus escitalopram, the CAMPION study","volume":"34","author":"Jeon","year":"2014","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2017.06.034_bib76","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/YCT.0000000000000238","article-title":"Episodic visual learning\/memory and attentional flexibility in patients with major depressive disorder after clinically effective electroconvulsive therapy","volume":"31","author":"Kalogerakou","year":"2015","journal-title":"J. ECT"},{"key":"10.1016\/j.jad.2017.06.034_bib77","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.4088\/JCP.09m05950gry","article-title":"Armodafinil as adjunctive therapy in adults with cognitive deficits associated with schizophrenia: a 4-week, double-blind, placebo-controlled study","volume":"71","author":"Kane","year":"2010","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2017.06.034_bib78","article-title":"Modafinil improves episodic memory and working memory cognition in patients with remitted depression: a double-blind, randomized, placebo-controlled study","author":"Kaser","year":"2016","journal-title":"Biol. Psychiatry: Cogn. Neurosci. Neuroimaging"},{"key":"10.1016\/j.jad.2017.06.034_bib79","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/YIC.0b013e3283542457","article-title":"A randomized, double-blind, placebo-controlled, duloxetine-referenced, fixed-dose study comparing the efficacy and safety of Lu AA21004 in elderly patients with major depressive disorder","volume":"27","author":"Katona","year":"2012","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2017.06.034_bib80","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jad.2016.02.050","article-title":"Long-term safety and efficacy of armodafinil in bipolar depression: a 6-month open-label extension study","volume":"197","author":"Ketter","year":"2016","journal-title":"J. Affect. Disord."},{"issue":"Suppl 1","key":"10.1016\/j.jad.2017.06.034_bib81","first-page":"S18","article-title":"Effect of tianeptine on cognitive functions in patients with depressive disorders during a 3-month observation","volume":"23","author":"Klasik","year":"2011","journal-title":"Psychiatr. Danub."},{"key":"10.1016\/j.jad.2017.06.034_bib82","doi-asserted-by":"crossref","first-page":"32","DOI":"10.4088\/JCP.09m05536gry","article-title":"A double-blind, placebo-controlled study of armodafinil for excessive sleepiness in patients with treated obstructive sleep apnea and comorbid depression","volume":"71","author":"Krystal","year":"2010","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2017.06.034_bib83","article-title":"Cognitive outcome after ventral capsule\/ventral striatum stimulation for treatment-resistant major depression","author":"Kubu","year":"2016","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jad.2017.06.034_bib84","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jad.2006.03.029","article-title":"Effects of repetitive transcranial magnetic stimulation on [11C]raclopride binding and cognitive function in patients with depression","volume":"95","author":"Kuroda","year":"2006","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2017.06.034_bib85","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jad.2016.05.074","article-title":"The effects of desvenlafaxine on neurocognitive and work functioning in employed outpatients with major depressive disorder","volume":"203","author":"Lam","year":"2016","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2017.06.034_bib86","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/01.JGP.0000192503.10692.9f","article-title":"Methylphenidate-enhanced antidepressant response to citalopram in the elderly: a double-blind, placebo-controlled pilot trial","volume":"14","author":"Lavretsky","year":"2006","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.jad.2017.06.034_bib87","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1097\/JGP.0b013e31820ee9ef","article-title":"Complementary use of tai chi chih augments escitalopram treatment of geriatric depression: a randomized controlled trial","volume":"19","author":"Lavretsky","year":"2011","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.jad.2017.06.034_bib88","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1176\/appi.ajp.2014.14070889","article-title":"Citalopram, methylphenidate, or their combination in geriatric depression: a randomized, double-blind, placebo-controlled trial","volume":"172","author":"Lavretsky","year":"2015","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2017.06.034_bib89","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jad.2011.10.023","article-title":"A meta-analysis of cognitive deficits in first-episode Major Depressive Disorder","volume":"140","author":"Lee","year":"2012","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2017.06.034_bib90","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1017\/S0033291712002127","article-title":"Cognitive remediation improves memory and psychosocial functioning in first-episode psychiatric out-patients","volume":"43","author":"Lee","year":"2013","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jad.2017.06.034_bib91","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1176\/ajp.152.4.564","article-title":"Antidepressant and cognitive effects of twice- versus three-times-weekly ECT","volume":"152","author":"Lerer","year":"1995","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2017.06.034_bib92","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.brs.2009.08.002","article-title":"Deep transcranial magnetic stimulation over the prefrontal cortex: evaluation of antidepressant and cognitive effects in depressive patients","volume":"2","author":"Levkovitz","year":"2009","journal-title":"Brain Stimul."},{"key":"10.1016\/j.jad.2017.06.034_bib93","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.jad.2011.04.059","article-title":"Effects of S-adenosylmethionine augmentation of serotonin-reuptake inhibitor antidepressants on cognitive symptoms of major depressive disorder","volume":"136","author":"Levkovitz","year":"2012","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2017.06.034_bib94","unstructured":"Lisdexamfetamine Dimesylate in Residual Symptoms and Cognitive Impairment in Major Depressive Disorder \u2013 Full Text View \u2013 ClinicalTrials.gov [WWW Document], n.d. URL \u3008https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01148979\u3009."},{"key":"10.1016\/j.jad.2017.06.034_bib95","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1016\/j.psyneuen.2013.05.014","article-title":"Oxytocin and psychotherapy: a pilot study of its physiological, behavioral and subjective effects in males with depression","volume":"38","author":"MacDonald","year":"2013","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.jad.2017.06.034_bib96","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jad.2016.11.039","article-title":"Biological mechanisms of depression following treatment with interferon for chronic hepatitis C: a critical systematic review","volume":"209","author":"Machado","year":"2017","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2017.06.034_bib97","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1016\/j.jagp.2013.11.002","article-title":"Cognitive outcomes after psychotherapeutic interventions for major depression in older adults with executive dysfunction","volume":"22","author":"Mackin","year":"2014","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.jad.2017.06.034_bib98","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1038\/npp.2013.334","article-title":"Lisdexamfetamine dimesylate augmentation in adults with persistent executive dysfunction after partial or full remission of major depressive disorder","volume":"39","author":"Madhoo","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2017.06.034_bib99","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.pnpbp.2012.10.005","article-title":"Oxytocin in postnatally depressed mothers: its influence on mood and expressed emotion","volume":"40","author":"Mah","year":"2013","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2017.06.034_bib100","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/da.22245","article-title":"Oxytocin promotes protective behavior in depressed mothers: a pilot study with the enthusiastic stranger paradigm","volume":"32","author":"Mah","year":"2015","journal-title":"Depression Anxiety"},{"key":"10.1016\/j.jad.2017.06.034_bib101","first-page":"1","article-title":"The effects of intranasal oxytocin administration on sensitive caregiving in mothers with postnatal depression","author":"Mah","year":"2016","journal-title":"Child Psychiatry Hum. Dev."},{"key":"10.1016\/j.jad.2017.06.034_bib102","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1038\/npp.2015.52","article-title":"A randomized, placebo-controlled, active-reference, double-blind, flexible-dose study of the efficacy of vortioxetine on cognitive function in major depressive disorder","volume":"40","author":"Mahableshwarkar","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2017.06.034_bib103","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.pharep.2014.11.005","article-title":"Antidepressant-like effect of modafinil in mice: evidence for the involvement of the dopaminergic neurotransmission","volume":"67","author":"Mahmoudi","year":"2015","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.jad.2017.06.034_bib104","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/gps.3840","article-title":"Longitudinal studies of cerebral glucose metabolism in late-life depression and normal aging","volume":"28","author":"Marano","year":"2013","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.jad.2017.06.034_bib105","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jagp.2013.10.001","article-title":"Structural imaging in late-life depression: association with mood and cognitive responses to antidepressant treatment","volume":"23","author":"Marano","year":"2015","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.jad.2017.06.034_bib106","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1017\/S0033291715002287","article-title":"The acute and medium-term effects of treatment with electroconvulsive therapy on memory in patients with major depressive disorder","volume":"46","author":"Maric","year":"2016","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jad.2017.06.034_bib107","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.rpsm.2012.06.004","article-title":"Eficacia y patr\u00f3n de uso de la terapia electroconvulsiva de continuaci\u00f3n y mantenimiento en el trastorno depresivo mayor","volume":"5","author":"Mart\u00ednez-Amor\u00f3s","year":"2012","journal-title":"Rev. Psiquiatr. Salud Ment."},{"key":"10.1016\/j.jad.2017.06.034_bib108","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.euroneuro.2015.01.007","article-title":"Cognition as a target in schizophrenia, bipolar disorder and depression","volume":"25","author":"Martinez-Aran","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2017.06.034_bib109","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1159\/000049342","article-title":"Executive function in patients with remitted bipolar disorder and schizophrenia and its relationship with functional outcome","volume":"71","author":"Martinez-Aran","year":"2002","journal-title":"Psychother. Psychosom."},{"key":"10.1016\/j.jad.2017.06.034_bib110","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s40520-014-0194-2","article-title":"Effects of escitalopram on serum BDNF levels in elderly patients with depression: a preliminary report","volume":"26","author":"Martocchia","year":"2014","journal-title":"Aging Clin. Exp. Res."},{"key":"10.1016\/j.jad.2017.06.034_bib111","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1517\/14656566.8.11.1615","article-title":"Thiazolidinediones: novel treatments for cognitive deficits in mood disorders?","volume":"8","author":"McIntyre","year":"2007","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.jad.2017.06.034_bib112","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.bbr.2012.09.021","article-title":"The neuroprotective effects of GLP-1: possible treatments for cognitive deficits in individuals with mood disorders","volume":"237","author":"McIntyre","year":"2013","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.jad.2017.06.034_bib113","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1017\/S1461145714000546","article-title":"A randomized, double-blind, placebo-controlled study of vortioxetine on cognitive function in depressed adults","volume":"17","author":"McIntyre","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"Suppl 1","key":"10.1016\/j.jad.2017.06.034_bib114","first-page":"20","article-title":"Treating to target in major depressive disorder: response to remission to functional recovery","volume":"20","author":"McIntyre","year":"2015","journal-title":"CNS Spectr."},{"key":"10.1016\/j.jad.2017.06.034_bib115","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.comppsych.2014.08.051","article-title":"The impact of cognitive impairment on perceived workforce performance: results from the International Mood Disorders Collaborative Project","volume":"56","author":"McIntyre","year":"2015","journal-title":"Compr. Psychiatry"},{"issue":"10","key":"10.1016\/j.jad.2017.06.034_bib116","doi-asserted-by":"crossref","first-page":"pyw055","DOI":"10.1093\/ijnp\/pyw055","article-title":"The effects of vortioxetine on cognitive function in patients with major depressive disorder (MDD): a meta-analysis of three randomized controlled trials","volume":"19","author":"McIntyre","year":"2016","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2017.06.034_bib117","unstructured":"Memory Flexibility Training for Depression [WWW Document], n.d. URL \u3008https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02371291\u3009."},{"key":"10.1016\/j.jad.2017.06.034_bib118","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1038\/sj.npp.1301534","article-title":"Modafinil: a review of neurochemical actions and effects on cognition","volume":"33","author":"Minzenberg","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2017.06.034_bib119","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.2174\/1871527313666141130205713","article-title":"\u201cHot\u201d cognition in major depressive disorder: a systematic review","volume":"13","author":"Miskowiak","year":"2014","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.jad.2017.06.034_bib120","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00213-010-1842-7","article-title":"Erythropoietin modulates neural and cognitive processing of emotional information in biomarker models of antidepressant drug action in depressed patients","volume":"210","author":"Miskowiak","year":"2010","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jad.2017.06.034_bib121","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1038\/npp.2013.335","article-title":"Recombinant human erythropoietin for treating treatment-resistant depression: a double-blind, randomized, placebo-controlled phase 2 trial","volume":"39","author":"Miskowiak","year":"2014","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.jad.2017.06.034_bib122","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/acps.12597","article-title":"Effects of erythropoietin on memory-relevant neurocircuitry activity and recall in mood disorders","volume":"134","author":"Miskowiak","year":"2016","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jad.2017.06.034_bib123","doi-asserted-by":"crossref","first-page":"e756","DOI":"10.1038\/tp.2016.29","article-title":"Meta-analysis and meta-regression of omega-3 polyunsaturated fatty acid supplementation for major depressive disorder","volume":"6","author":"Mocking","year":"2016","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.jad.2017.06.034_bib124","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1017\/S0033291707001663","volume":"38","author":"Mogg","year":"2008","journal-title":"Psychol. Med. (2008)"},{"key":"10.1016\/j.jad.2017.06.034_bib125","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jad.2016.03.062","article-title":"Significantly improved neurocognitive function in major depressive disorders 6 weeks after ECT","volume":"202","author":"Mohn","year":"2016","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2017.06.034_bib126","doi-asserted-by":"crossref","first-page":"4579","DOI":"10.1038\/ncomms5579","article-title":"Neuroplasticity-based computerized cognitive remediation for treatment-resistant geriatric depression","volume":"5","author":"Morimoto","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jad.2017.06.034_bib127","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00415-012-6663-7","article-title":"Lisdexamfetamine dimesylate improves processing speed and memory in cognitively impaired MS patients: a phase II study","volume":"260","author":"Morrow","year":"2013","journal-title":"J. Neurol."},{"key":"10.1016\/j.jad.2017.06.034_bib128","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1212\/WNL.58.8.1288","article-title":"Improved executive functioning following repetitive transcranial magnetic stimulation","volume":"58","author":"Moser","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.jad.2017.06.034_bib129","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jad.2015.09.022","article-title":"Computerized cognitive training and functional recovery in major depressive disorder: a meta-analysis","volume":"189","author":"Motter","year":"2016","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2017.06.034_bib130","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00213-004-1926-3","article-title":"Effects of modafinil on working memory processes in humans","volume":"177","author":"M\u00fcller","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jad.2017.06.034_bib131","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/npp.2014.298","article-title":"Neurocognitive effects of ketamine and association with antidepressant response in individuals with treatment-resistant depression: a randomized controlled trial","volume":"40","author":"Murrough","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2017.06.034_bib132","doi-asserted-by":"crossref","first-page":"5760141","DOI":"10.1155\/2016\/5760141","article-title":"Neuromodulation of attentional control in major depression: a Pilot DeepTMS Study","volume":"2016","author":"Naim-Feil","year":"2016","journal-title":"Neural Plast."},{"key":"10.1016\/j.jad.2017.06.034_bib133","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/JGP.0b013e3181dba587","article-title":"Enhancing memory in late-life depression: the effects of a combined psychoeducation and cognitive training program","volume":"19","author":"Naismith","year":"2011","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.jad.2017.06.034_bib134","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0022-3956(02)00085-7","article-title":"Persistence of cognitive impairment in geriatric patients following antidepressant treatment: a randomized, double-blind clinical trial with nortriptyline and paroxetine","volume":"37","author":"Nebes","year":"2003","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2017.06.034_bib135","unstructured":"Neurocognition and Work Productivity in Major Depressive Disorder (MDD) \u2013 Full Text View \u2013 ClinicalTrials.gov [WWW Document], n.d. URL \u3008https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01468610\u3009."},{"key":"10.1016\/j.jad.2017.06.034_bib136","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/00124509-200012000-00007","article-title":"Efficacy and cognitive effects of right unilateral electroconvulsive therapy","volume":"16","author":"Ng","year":"2000","journal-title":"J. ECT"},{"key":"10.1016\/j.jad.2017.06.034_bib137","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/00004714-200304000-00008","article-title":"Clinical and neurobiological effects of tianeptine and paroxetine in major depression","volume":"23","author":"Nickel","year":"2003","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2017.06.034_bib138","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1517\/17425255.2012.708338","article-title":"Pharmacokinetic evaluation of armodafinil for the treatment of bipolar depression","volume":"8","author":"Niemegeers","year":"2012","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.jad.2017.06.034_bib139","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/01.wnn.0000187938.73918.33","article-title":"The effects of repetitive transcranial magnetic stimulation (rTMS) on procedural memory and dysphoric mood in patients with major depressive disorder","volume":"18","author":"O\u2019Connor","year":"2005","journal-title":"Cogn. Behav. Neurol."},{"key":"10.1016\/j.jad.2017.06.034_bib140","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00406-014-0485-9","article-title":"Effects of aerobic exercise on cognitive performance and individual psychopathology in depressive and schizophrenia patients","volume":"264","author":"Oertel-Knochel","year":"2014","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.jad.2017.06.034_bib141","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1002\/hup.970","article-title":"Quetiapine augmentation in depressed patients with partial response to antidepressants","volume":"23","author":"Olver","year":"2008","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.jad.2017.06.034_bib142","first-page":"525","article-title":"Memantine add on to citalopram in elderly patients with depression: a double-blind placebo-controlled study","volume":"19","author":"Omranifard","year":"2014","journal-title":"J. Res. Med. Sci."},{"key":"10.1016\/j.jad.2017.06.034_bib143","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jad.2015.10.059","article-title":"Screening for cognitive dysfunction in unipolar depression: validation and evaluation of objective and subjective tools","volume":"190","author":"Ott","year":"2016","journal-title":"J. Affect. Disord."},{"issue":"8","key":"10.1016\/j.jad.2017.06.034_bib144","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/j.euroneuro.2016.05.009","article-title":"The effect of erythropoietin on cognition in affective disorders - Associations with baseline deficits and change in subjective cognitive complaints","volume":"26","author":"Ott","year":"2016","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2017.06.034_bib145","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/npp.2014.181","article-title":"Mineralocorticoid receptor stimulation improves cognitive function and decreases cortisol secretion in depressed patients and healthy individuals","volume":"40","author":"Otte","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2017.06.034_bib146","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jpsychires.2015.08.001","article-title":"Cognitive function in older adults with major depression: effects of mineralocorticoid receptor stimulation","volume":"69","author":"Otte","year":"2015","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2017.06.034_bib147","doi-asserted-by":"crossref","first-page":"16065","DOI":"10.1038\/nrdp.2016.65","article-title":"Major depressive disorder","volume":"2","author":"Otte","year":"2016","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.jad.2017.06.034_bib148","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/gps.1958","article-title":"Randomized double-blind placebo-controlled donepezil augmentation in antidepressant-treated elderly patients with depression and cognitive impairment: a pilot study","volume":"23","author":"Pelton","year":"2008","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.jad.2017.06.034_bib149","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.cct.2013.11.015","article-title":"Donepezil treatment of older adults with cognitive impairment and depression (DOTCODE study): clinical rationale and design","volume":"37","author":"Pelton","year":"2014","journal-title":"Contemp. Clin. Trials"},{"key":"10.1016\/j.jad.2017.06.034_bib150","first-page":"648","article-title":"Combined treatment with memantine\/es-citalopram for older depressed patients with cognitive impairment: a pilot study","author":"Pelton","year":"2015","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.jad.2017.06.034_bib151","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fpsyt.2010.00134","article-title":"Inverse effects of oxytocin on attributing mental activity to others in depressed and healthy subjects: a double-blind placebo controlled fMRI study","volume":"1","author":"Pincus","year":"2010","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.jad.2017.06.034_bib152","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jad.2014.11.008","article-title":"Cognitive tolerability following successful long term treatment of major depression and anxiety disorders with SSRi antidepressants","volume":"173","author":"Popovic","year":"2015","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2017.06.034_bib153","unstructured":"Probiotic Supplementation in Severe Depression- Full Text View \u2013 ClinicalTrials.gov [WWW Document], n.d. URL \u3008https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02957591\u3009."},{"key":"10.1016\/j.jad.2017.06.034_bib154","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/00124509-200106000-00008","article-title":"Subtypes of memory dysfunction associated with ECT: characteristics and neurobiological bases","volume":"17","author":"Rami-Gonzalez","year":"2001","journal-title":"J. ECT"},{"key":"10.1016\/j.jad.2017.06.034_bib155","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1176\/ajp.2007.164.6.900","article-title":"Efficacy of duloxetine on cognition, depression, and pain in elderly patients with major depressive disorder: an 8-week, double-blind, placebo-controlled trial","volume":"164","author":"Raskin","year":"2007","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2017.06.034_bib156","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1177\/0269881116631649","article-title":"The effect of desvenlafaxine on cognitive functioning in employed outpatients with major depressive disorder: a substudy of a randomized, double-blind, placebo-controlled trial","volume":"30","author":"Reddy","year":"2016","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jad.2017.06.034_bib157","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1176\/ajp.153.10.1288","article-title":"Treatment outcome in recurrent major depression: a post hoc comparison of elderly (\u201cyoung old\u201d) and midlife patients","volume":"153","author":"Reynolds","year":"1996","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2017.06.034_bib158","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1001\/archgenpsychiatry.2010.184","article-title":"Maintenance treatment of depression in old age: a randomized, double-blind, placebo-controlled evaluation of the efficacy and safety of donepezil combined with antidepressant pharmacotherapy","volume":"68","author":"Reynolds","year":"2011","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2017.06.034_bib159","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jad.2016.07.006","article-title":"Lisdexamfetamine dimesylate augmentation for adults with major depressive disorder and inadequate response to antidepressant monotherapy: results from 2 phase 3, multicenter,randomized, double-blind, placebo-controlled studies","volume":"206","author":"Richards","year":"2016","journal-title":"J. Affect. Disord."},{"issue":"10047","key":"10.1016\/j.jad.2017.06.034_bib160","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0140-6736(16)31140-0","article-title":"Cost and Outcome of Behavioural Activation versus Cognitive Behavioural Therapy for Depression (COBRA): a randomised, controlled, non-inferiority trial","volume":"388","author":"Richards","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jad.2017.06.034_bib161","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1192\/bjp.168.2.149","article-title":"Moclobemide in elderly patients with cognitive decline and depression: an international double-blind, placebo-controlled trial","volume":"168","author":"Roth","year":"1996","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2017.06.034_bib162","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1056\/NEJM199303253281204","article-title":"Effects of stimulus intensity and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy","volume":"328","author":"Sackeim","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jad.2017.06.034_bib163","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0278-5846(98)00007-4","article-title":"Tianeptine therapy for depression in the elderly","volume":"22","author":"Saiz-Ruiz","year":"1998","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2017.06.034_bib164","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jad.2016.04.047","article-title":"Statins for the treatment of depression: a meta-analysis of randomized, double-blind, placebo-controlled trials","volume":"200","author":"Salagre","year":"2016","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2017.06.034_bib165","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.rpsm.2017.02.001","article-title":"El cerebro visceral: trastorno bipolar y microbiota","volume":"10","author":"Salagre","year":"2017","journal-title":"Rev. Psiquiatr Salud Ment."},{"key":"10.1016\/j.jad.2017.06.034_bib166","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jad.2016.12.036","article-title":"Cognitive control dysfunction in emotion dysregulation and psychopathology of major depression (MD): evidence from transcranial brain stimulation of the dorsolateral prefrontal cortex (DLPFC)","volume":"210","author":"Salehinejad","year":"2016","journal-title":"J. Affect. Disord."},{"issue":"1","key":"10.1016\/j.jad.2017.06.034_bib167","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11920-017-0752-3","article-title":"Treatment of functional impairment in patients with bipolar disorder","volume":"19","author":"Sanchez-Moreno","year":"2017","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.jad.2017.06.034_bib168","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1176\/appi.ajp.2016.15091228","article-title":"Adjunctive nutraceuticals for depression: a systematic review and meta-analyses","volume":"173","author":"Sarris","year":"2016","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2017.06.034_bib169","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.biopsych.2010.06.009","article-title":"Objective cognitive performance associated with electroconvulsive therapy for depression: a systematic review and meta-analysis","volume":"68","author":"Semkovska","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2017.06.034_bib170","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0278-5846(02)00210-5","article-title":"Left dorso-lateral repetitive transcranial magnetic stimulation affects cortical excitability and functional connectivity, but does not impair cognition in major depression","volume":"26","author":"Shajahan","year":"2002","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2017.06.034_bib171","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1017\/S1461145714001011","article-title":"Neurocognitive performance and serial intravenous subanesthetic ketamine in treatment-resistant depression","volume":"17","author":"Shiroma","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2017.06.034_bib172","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000448957","article-title":"Gut microbiota, bacterial translocation, and interactions with diet: pathophysiological links between major depressive disorder and non-communicable medical comorbidities","volume":"86","author":"Slyepchenko","year":"2017","journal-title":"Psychother. Psychosom."},{"key":"10.1016\/j.jad.2017.06.034_bib173","doi-asserted-by":"crossref","first-page":"966","DOI":"10.4088\/JCP.12m08252","article-title":"Antidepressant augmentation using the N-methyl-D-aspartate antagonist memantine: a randomized, double-blind, placebo-controlled trial","volume":"74","author":"Smith","year":"2013","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2017.06.034_bib174","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.psychres.2014.06.053","article-title":"The effect of bupropion XL and escitalopram on memory and functional outcomes in adults with major depressive disorder: results from a randomized controlled trial","volume":"220","author":"Soczynska","year":"2014","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2017.06.034_bib175","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.euroneuro.2014.12.004","article-title":"Cognition as a target in major depression: new developments","volume":"25","author":"Sole","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2017.06.034_bib176","unstructured":"Study of Duloxetine in Elderly Patients With Major Depressive Disorder, [WWW Document], n.d. URL: \u3008https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00062673\u3009."},{"key":"10.1016\/j.jad.2017.06.034_bib177","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.jpsychires.2015.04.024","article-title":"Changes in cognitive symptoms after a buspirone-melatonin combination treatment for Major Depressive Disorder","volume":"68","author":"Targum","year":"2015","journal-title":"J. Psychiatr. Res."},{"issue":"6","key":"10.1016\/j.jad.2017.06.034_bib178","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.euroneuro.2016.03.007","article-title":"A meta-analysis of randomized, placebo-controlled trials of vortioxetine for the treatment of major depressive disorder in adults","volume":"26","author":"Thase","year":"2016","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2017.06.034_bib179","unstructured":"The Effects of JNJ-39393406 on Psychometric Performance and Residual Depressive \u2013 Full Text View \u2013 ClinicalTrials.gov [WWW Document], n.d. URL \u3008https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02677207\u3009."},{"key":"10.1016\/j.jad.2017.06.034_bib180","unstructured":"The Effects of Quetiapine XR on Cognition, Mood and Anxiety Symptoms in SSRI-Resistant Unipolar Depression \u2013 Full Text View \u2013 ClinicalTrials.gov [WWW Document], n.d. URL \u3008https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00517387\u3009."},{"key":"10.1016\/j.jad.2017.06.034_bib181","unstructured":"The Efficacy, Safety, and Tolerability of Probiotics on the Mood and Cognition of Depressed Patients \u2013 Full Text View \u2013 ClinicalTrials.gov [WWW Document], n.d. URL \u3008https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02838043\u3009."},{"key":"10.1016\/j.jad.2017.06.034_bib182","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/clpt.2013.39","article-title":"A randomized trial on the acute and steady-state effects of a new antidepressant, vortioxetine (Lu AA21004), on actual driving and cognition","volume":"93","author":"Theunissen","year":"2013","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.jad.2017.06.034_bib183","doi-asserted-by":"crossref","first-page":"28028","DOI":"10.1038\/srep28028","article-title":"Venlafaxine treatment reduces the deficit of executive control of attention in patients with major depressive disorder","volume":"6","author":"Tian","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jad.2017.06.034_bib184","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1177\/0004867415622271","article-title":"Cognitive remediation for depressed inpatients: results of a pilot randomized controlled trial","volume":"50","author":"Trapp","year":"2016","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.jad.2017.06.034_bib185","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1177\/0269881104042622","article-title":"A double-blind, randomized, 26-week study comparing the cognitive and psychomotor effects and efficacy of 75 mg (37.5 mg b.i.d.) venlafaxine and 75 mg (25 mg mane, 50 mg nocte) dothiepin in elderly patients with moderate major depression being treated in","volume":"18","author":"Trick","year":"2004","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jad.2017.06.034_bib186","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1176\/appi.ajp.163.1.28","article-title":"Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice","volume":"163","author":"Trivedi","year":"2006","journal-title":"Am. J. Psychiatry"},{"issue":"8","key":"10.1016\/j.jad.2017.06.034_bib187","doi-asserted-by":"crossref","first-page":"802","DOI":"10.4088\/JCP.13m08360","article-title":"A randomized controlled trial of the efficacy and safety of lisdexamfetamine dimesylate as augmentation therapy in adults with residual symptoms of major depressive disorder after treatment with escitalopram","volume":"74","author":"Trivedi","year":"2013","journal-title":"J. Clin. Psychiatry"},{"issue":"4","key":"10.1016\/j.jad.2017.06.034_bib188","doi-asserted-by":"crossref","first-page":"pyv135","DOI":"10.1093\/ijnp\/pyv135","article-title":"Glucocorticoid receptors, brain-derived neurotrophic factor, serotonin and dopamine neurotransmission are associated with interferon-induced depression","volume":"19","author":"Udina","year":"2016","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2017.06.034_bib189","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1080\/15622970701816514","article-title":"A single session of rTMS over the left dorsolateral prefrontal cortex influences attentional control in depressed patients","volume":"10","author":"Vanderhasselt","year":"2009","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2017.06.034_bib190","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1590\/S1807-59322011000900008","article-title":"Acute exercise improves cognition in the depressed elderly: the effect of dual-tasks","volume":"66","author":"Vasques","year":"2011","journal-title":"Clinics"},{"issue":"10067","key":"10.1016\/j.jad.2017.06.034_bib191","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0140-6736(17)30159-9","article-title":"Behavioural activation training for depression","volume":"389","author":"Vieta","year":"2017","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.jad.2017.06.034_bib192","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/wps.20351","article-title":"Functional remediation: the pathway from remission to recovery in bipolar disorder","volume":"15","author":"Vieta","year":"2016","journal-title":"World Psychiatry"},{"issue":"4","key":"10.1016\/j.jad.2017.06.034_bib193","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.euroneuro.2013.12.008","article-title":"Efficacy and tolerability of flexibly-dosed adjunct TC-5214 (dexmecamylamine) in patients with major depressive disorder and inadequate response to prior antidepressant","volume":"24","author":"Vieta","year":"2014","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2017.06.034_bib194","first-page":"344","article-title":"Association between decline in brain dopamine activity with age and cognitive and motor impairment in healthy individuals","volume":"155","author":"Volkow","year":"1998","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2017.06.034_bib195","unstructured":"Vortioxetine for Menopausal Depression \u2013 Full Text View \u2013 ClinicalTrials.gov [WWW Document], n.d. URL \u3008https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02234362\u3009."},{"key":"10.1016\/j.jad.2017.06.034_bib196","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/YCT.0000000000000096","article-title":"No change in neuropsychological functioning after receiving repetitive transcranial magnetic stimulation treatment for major depression","volume":"30","author":"Wajdik","year":"2014","journal-title":"J. ECT"},{"key":"10.1016\/j.jad.2017.06.034_bib197","unstructured":"WHO, 2012. Depression, a global public health concern. WHO Dep. Ment. Heal. Subst. Abus. pp. 1\u20138."},{"key":"10.1016\/j.jad.2017.06.034_bib198","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1749-6632.1995.tb17403.x-i1","article-title":"Antidepressant and cognition-enhancing effects of DHEA in major depression","volume":"774","author":"Wolkowitz","year":"1995","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jad.2017.06.034_bib199","unstructured":"World Health Organizaton, 2014. Health for the World\u2019s Adolescents a Second Chance in the Second Decade: Summary. pp. 1\u201320."},{"key":"10.1016\/j.jad.2017.06.034_bib200","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/01.jcp.0000227699.26375.f8","article-title":"Mood and neuropsychological changes in women with midlife depression treated with escitalopram","volume":"26","author":"Wroolie","year":"2006","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2017.06.034_bib201","doi-asserted-by":"crossref","first-page":"4359","DOI":"10.2174\/092986711797200471","article-title":"Promoting adult hippocampal neurogenesis: a novel strategy for antidepressant drug screening","volume":"18","author":"Yan","year":"2011","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.jad.2017.06.034_bib202","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/YCT.0b013e3182a4b4c6","article-title":"Comparing effects of ketamine and thiopental administration during electroconvulsive therapy in patients with major depressive disorder: a randomized, double-blind study","volume":"30","author":"Yoosefi","year":"2014","journal-title":"J. ECT"},{"key":"10.1016\/j.jad.2017.06.034_bib203","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1038\/sj.npp.1300471","article-title":"Improvements in neurocognitive function and mood following adjunctive treatment with mifepristone (RU-486) in bipolar disorder","volume":"29","author":"Young","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2017.06.034_bib204","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.psychres.2012.09.007","article-title":"Use of lisdexamfetamine dimesylate in treatment of executive functioning deficits and chronic fatigue syndrome: a double blind, placebo-controlled study","volume":"207","author":"Young","year":"2013","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2017.06.034_bib205","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s12264-016-0030-0","article-title":"Molecular, functional, and structural imaging of major depressive disorder","volume":"32","author":"Zhang","year":"2016","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.jad.2017.06.034_bib206","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jad.2016.05.011","article-title":"Mood and neuropsychological effects of different doses of ketamine in electroconvulsive therapy for treatment-resistant depression","volume":"201","author":"Zhong","year":"2016","journal-title":"J. Affect. Disord."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032717304184?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032717304184?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T21:44:35Z","timestamp":1719265475000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032717304184"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":206,"alternative-id":["S0165032717304184"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2017.06.034","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of neurocognitive symptoms in unipolar depression: A systematic review and future perspectives","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2017.06.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}